A gene × gene interaction between DRD2 and DRD4 is associated with conduct disorder and antisocial behavior in males by Beaver, Kevin M et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
Behavioral and Brain Functions
Open Access Research
A gene × gene interaction between DRD2 and DRD4 is associated 
with conduct disorder and antisocial behavior in males
Kevin M Beaver*1, John Paul Wright2, Matt DeLisi3, Anthony Walsh4, 
Michael G Vaughn5, Danielle Boisvert2 and Jamie Vaske2
Address: 1College of Criminology and Criminal Justice, Florida State University, Tallahassee, FL 32306-1127, USA, 2Division of Criminal Justice, 
University of Cincinnati, Cincinnati, OH 45221-0389, USA, 3Department of Sociology, Iowa State University, Ames, IA 50011-1070, USA, 
4Department of Criminal Justice Administration, Boise State University, Boise, ID 83725, USA and 5School of Social Work, University of 
Pittsburgh, Pittsburgh, PA 15260, USA
Email: Kevin M Beaver* - kbeaver@fsu.edu; John Paul Wright - john.wright@uc.edu; Matt DeLisi - delisi@iastate.edu; 
Anthony Walsh - twalsh@boisestate.edu; Michael G Vaughn - mgv6@pitt.edu; Danielle Boisvert - boisved@email.uc.edu; 
Jamie Vaske - vaskeje@email.uc.edu
* Corresponding author    
Abstract
Background:  Antisocial behaviors are complex polygenic phenotypes that are due to a
multifactorial arrangement of genetic polymorphisms. Little empirical research, however, has been
undertaken that examines gene × gene interactions in the etiology of conduct disorder and
antisocial behavior. This study examined whether adolescent conduct disorder and adult antisocial
behavior were related to the dopamine D2 receptor polymorphism (DRD2) and the dopamine D4
receptor polymorphism (DRD4).
Methods: A sample of 872 male participants from the National Longitudinal Study of Adolescent
Health (Add Health) completed self-report questionnaires that tapped adolescent conduct
disorder and adult antisocial behavior. DNA was genotyped for DRD2 and DRD4.
Results: Multivariate regression analysis revealed that neither DRD2 nor DRD4 had significant
independent effects on conduct disorder or antisocial behavior. However, DRD2 interacted with
DRD4 to predict variation in adolescent conduct disorder and in adult antisocial behavior.
Conclusion: The results suggest that a gene × gene interaction between DRD2 and DRD4 is
associated with the development of conduct disorder and adult antisocial behavior in males.
Background
Adolescent conduct disorder (CD) and adult antisocial
behavior are highly heritable phenotypes. Studies using
twin designs and model-fitting techniques indicate that
up to 85 percent of the variance in these disorders may be
attributable to genetic influences[1,2]. However, the pre-
cise genetic polymorphisms implicated in the etiology of
antisocial behaviors remain elusive. The most consistent
findings suggest that genes related to the modulation of
neurotransmitters may be associated with the develop-
ment of maladaptive behaviors. For example, in a multi-
variate analysis of associations, Comings and his
coauthors[3] examined 42 dopamine, serotonin, and
norepinephrine genes on attention deficit hyperactivity
disorder (ADHD), oppositional defiant disorder (ODD),
and CD phenotypes. Their analyses revealed that CD was
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associated with multiple hormone and neuropeptide
genes (CCK, CYP19, ESR1, and INS). In a similar vein,
Caspi et al[4] examined whether the monoamine oxidase
A (MAOA) polymorphism was associated with different
types of antisocial conduct. Their analysis of 442 Cauca-
sian males from the Dunedin Longitudinal Study revealed
that MAOA did not have a significant direct effect on crim-
inal or violent behaviors. However, MAOA interacted with
childhood maltreatment to predict variation in criminal
behavior. Other studies on MAOA have produced mixed
results [5-7].
Taken together, empirical evidence suggests that antisocial
conduct constitutes a polygenic phenotype, with the
effects of some polymorphisms conditioned by the pos-
session of other polymorphisms – that is, a gene × gene
interaction[3]. However, we know of no research that has
reported a gene × gene interaction on a CD behavioral
phenotype. Limited evidence suggests that some genes
and some proteins may act synergistically to create certain
diseases and disorders[8]. MnSOD and GPX-1, for exam-
ple, have been found to interact to increase the risk of
developing breast cancer[9].
The most compelling evidence to suggest that gene × gene
interactions may be implicated in the development of cer-
tain phenotypes comes from three studies. The first study,
conducted by Noble and colleagues[10], examined the
effect that two dopamine receptor genes (DRD2 and
DRD4) had on personality traits. The results of their anal-
ysis revealed a significant interaction between minor vari-
ants of the DRD2 gene and the 7-repeat allele of DRD4 in
the creation of novelty seeking. Another set of researchers
attempting to replicate this finding failed to detect a sig-
nificant gene × gene interaction[11].
The second study, carried out by Carrasco et al[12] exam-
ined the independent and interactive effects of DRD4 and
DAT1 on ADHD in a sample of Chilean families. They
employed a family-based discordant sib-pair analysis,
which indicated that DRD4 and DAT1 failed to have sig-
nificant and independent effects on ADHD. However,
individuals who possessed both the 7-repeat allele of the
DRD4 gene and the 10-repeat allele of the DAT1 gene
were significantly more likely to be diagnosed with ADHD
(odds-ratio = 12.71) when compared to those subjects
with none or just one of these risk alleles.
In the third study, Eisenberg and his colleagues[13] ana-
lyzed data drawn from a sample of college students to esti-
mate the effects of DRD2 and DRD4 on a behavioral
measure of impulsivity. The results of their study revealed
that DRD2 had a statistically significant main effect on
impulsivity, but DRD4 did not. Additional analyses indi-
cated that DRD2 and DRD4 interacted to predict variation
in the measure of impulsivity.
Together these three studies provide some empirical evi-
dence indicating that dopaminergic genes may interact to
produce novelty-seeking, ADHD, and impulsivity. These
findings are particularly important in selecting genetic
polymorphisms that may also be implicated in the devel-
opment of antisocial phenotypes because ADHD and
impulsivity are highly comorbid with aggression and vio-
lence[14]. Moreover, several recent studies have revealed
that the covariation among ADHD, impulsivity, conduct
disorder, and oppositional defiant disorder is due, in large
part, to shared genetic effects[15,16]. Thus genes that are
associated with ADHD may also be the same genes that
are associated with antisocial behavioral phenotypes.
Even though significant gene × gene interactions have not
been extended to an antisocial behavioral phenotype, a
number of lines of research converge to show that
dopaminergic polymorphisms have independent effects
on a wide array of maladaptive and antisocial phenotypes,
such as compulsive gambling, alcohol consumption, and
antisocial personality traits[3,17-19]. These studies sug-
gest that dopaminergic genes may be etiologically related
to conduct disorder and to antisocial behavior. From this
research, two genetic polymorphisms have been identi-
fied as potentially important contributors to antisocial
phenotypes: the dopamine D2 receptor gene (DRD2) and
the dopamine D4 receptor gene (DRD4). DRD2 is a mem-
ber of the D2 receptor family and has been mapped to
chromosome 11 at location 11q23[20,21]. DRD2 codes
for the D2 receptor and is found throughout the body, but
especially in the striatum, the pituitary gland, the amy-
gdala, the caudatus, the putamen, and other regions of the
brain[22].
The A-1 allele of the DRD2 gene is considered the risk
allele for antisocial phenotypes. Research investigating
the functional role of the A-1 allele has found that carriers
of this allele, in contrast to carriers of the A-2 allele, have
fewer brain D2 dopamine receptors[23,24], have dimin-
ished glucose metabolism in the brain[25], are more
attuned and responsive to stress[26], and exhibit reduced
dopaminergic activity in the central nervous system[23].
As a result of the findings from these studies, the A-1 allele
of DRD2 has been tagged as a contributor to the "reward
deficiency syndrome" of the human body[27,28].
DRD4 has been mapped to chromosome 11 at location
11p15.5[29]. Similar to DRD2, DRD4 also belongs to the
D2 dopamine family but manufactures the D4 dopamine
receptor protein instead of the D2 dopamine receptor pro-
tein. The D4 dopamine receptor protein is found in areas
of the brain that are responsible for the expression ofBehavioral and Brain Functions 2007, 3:30 http://www.behavioralandbrainfunctions.com/content/3/1/30
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emotions and for the stimulation of cognitive facul-
ties[30]. Like other genes in the dopaminergic system, the
DRD4 gene regulates attention processes, is partially
responsible for motivation, and has been linked to explor-
atory behaviors[30]. The 7-repeat allele has been shown
to mediate a blunted intracellular response to dopamine
and may also encode a postsynaptic receptor that is sub-
sensitive to dopamine[31]. The DRD4 polymorphism is
one of the most promising candidate genes to many
behavioral, psychiatric, and neuropsychological disor-
ders[32].
In this study, we test whether DRD2 and DRD4 are asso-
ciated with multiple measures of conduct disorder and
with a measure of antisocial behavior. A considerable
amount of research reveals, however, that complex phe-
notypes, such as antisocial behavior, are probably due to
multiple genes acting not only independently, but also
interactively. As a result, we also examine the possibility
that DRD2 and DRD4 interact to increase the likelihood
of evincing signs of antisocial behavior.
Methods
Study population
Subjects for this study come from the sibling-pairs sample
of the National Longitudinal Study of Adolescent Health
(Add Health). The Add Health is a prospective, nationally-
representative sample of American adolescents in seventh
through twelfth grade. Three rounds of interviews have
been conducted thus far. The first wave of data was col-
lected in 1994 when the participants were 11–19 years
old. Over 90,000 respondents were administered a self-
report survey at school. A random subsample of partici-
pants was then chosen to be interviewed at home and to
be followed longitudinally. Nearly 20,700 adolescents
and 17,700 of their primary caregivers (typically the
mother) were interviewed at home. Approximately two
years later, the second wave of questionnaires was com-
pleted by 14,738 participants. During 2001–2002, when
the respondents were 18–27 years of age, the third wave
of data was collected from 15,197 of the original Add
Health participants. Detailed information about the Add
Health research design and demographic statistics about
the sample have been presented elsewhere[6,33].
The Add Health data also contain a subsample of sibling
pairs. During wave 1 interviews, adolescents were asked
whether they lived with a co-twin, a half-sibling, an unre-
lated sibling (e.g., a stepsibling), or a cousin. If they did
live with a sibling, and if their sibling was between the
ages of 11 and 20, then their sibling was asked to partici-
pate in the study. A probability sample of full siblings was
also selected to be included in the sibling pairs sam-
ple[33]. Altogether, 5,470 siblings were included in the
wave 1 sample, 4,984 were included in the wave 2 sample,
and 4,356 were re-interviewed at wave 3[6].
During wave 3 interviews, a sample of N = 2,611 respond-
ents was selected from the sibling pairs data and asked to
submit samples of their DNA for genotyping. In line with
prior research[6], we only used data that were available for
males. We include both African American and non-His-
panic Caucasian males in our analytical data set (we
include a dichotomous dummy variable controlling for
race). Females were removed from the sample for two
main reasons. First, for females there was very little varia-
tion in the dependent variables, with less than one per-
cent of the sample of females scoring two standard
deviations above the mean on the outcome measures. Sec-
ond, preliminary analysis did not reveal any associations
among DRD2, DRD4, and measures of antisocial behav-
iors for females. With this selection criteria, and after
removing eighty-six cases that had missing data, and after
removing one twin from each MZ twin pair, we were left
with a final sample size of N = 872 male participants.
Measures
The Add Health data contain a number of items that
approximate some of the DSM-IV criteria for conduct dis-
order. We used these items to create a continuous conduct
disorder scale for each of the three waves of data. At wave
1, respondents were asked how many times in the past 12
months had they gotten into a serious physical fight, had
they hurt someone badly enough to need medical atten-
tion, had they used or threatened to use a weapon, and
had they taken part in a group fight. At wave 2, adoles-
cents were asked how many times in the past 12 months
had they used or threatened to use a weapon, had they
taken part in a group fight, and whether they had ever
been initiated into a named gang (0 = no, 1 = yes). At wave
3, participants were asked how many times in the past 12
months had they threatened to use a weapon, had they
taken part in a group fight, had they used a weapon in a
fight, and had they ever been initiated into a named gang
(0 = no, 1 = yes). Reponses to these items were coded as
follows: 0 = never, 1 = 1 or 2 times, 2 = 3 or 4 times, 3 = 5
or more times. For each wave, answers to the items were
summed together to form the conduct disorder scale at
wave 1, the conduct disorder scale at wave 2, and the con-
duct disorder scale at wave 3[6].
Following prior research[6], we also created a lifetime
conduct problems scale and a composite index of antiso-
cial behavior. The lifetime conduct problems scale was
created by summing the scores for the three conduct dis-
order scales and dividing by three. The resulting product
indexed the average conduct disorder score across the
three waves of data.Behavioral and Brain Functions 2007, 3:30 http://www.behavioralandbrainfunctions.com/content/3/1/30
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The composite index of antisocial behavior scale was
developed by transforming the lifetime conduct problems
measure into a standardized score (z-score). Respondents
who scored more than 1.5 standard deviations units
above the mean on this scale were assigned a value of "1,"
whereas participants scoring at or below 1.5 standard
deviation units below the mean were assigned a value of
"0." We also employed a one-item measure asking
respondents to indicate whether they had ever been con-
victed of a felony. Participants who responded affirma-
tively were assigned a value of "1"; all other respondents
were scored with a value of "0." Finally, the two items (i.e.,
the transformed conduct disorder scale and the violent
conviction scale) were added together to form the com-
posite index of antisocial behavior[6]. Scores on this scale
ranged from zero to two. Table 1 provides descriptive
information about each of the scales.
Race (0 = Caucasian, non-Hispanic, 1 = African American)
and age (measured in years) were included in the analysis
as control variables.
Genotyping
At wave 3, buccal cells were collected from respondents
and genotyped for DRD2 and DRD4. In the 3' untrans-
lated region of the DRD2 polymorphism is the site of
TaqIA, which was genotyped as a single nucleotide poly-
morphism (SNP). Geneticists working at the Institute for
Behavioral Genetics at the University of Colorado origi-
nated an SNP assay by employing the Applied Biosystem's
"Taqman© Assays by Design™ for SNP Genotyping Serv-
ice"[34]. To genotype the DRD2 TaqIA polymorphism,
the following primers and probes were used: forward
primer, 5'-GTGCAGCTCACTCCATCCT-3', reverse primer,
5'-GCAACACAGCCATCCTCAAAG-3', probe 1, 5'VIC-
CCTGCCTTGACCAGC-NFQMGB-3' and probe 2, 5'-
FAM-CTGCCTCGACCAGC-NFQMCB-3'[34]. The DRD2
polymorphisms were scored by two independent observ-
ers, where the T-probe signal corresponded to the TaqIA-
1 allele and the C-probe signal corresponded to the TaqIA-
2 allele. The DRD2 alleles were then summed together to
index the number of A-1 alleles that each subject pos-
sessed. Based on this nomenclature, 58 percent of the
sample possessed zero A-1 alleles, 35 percent of the sam-
ple possessed one A-1 allele, and 7 percent of the sample
possessed two A-1 alleles. The allelic distribution of the A-
1 allele was examined by race, which revealed that African
Americans possessed significantly more A-1 alleles than
non-Hispanic Caucasians (χ2 = 19.29, df = 2, p < .001).
The dopamine D4 receptor gene (DRD4) is a highly poly-
morphic gene that consists of a 48 base pair VNTR that can
be repeated 2 to 11 times, although 2, 4, and 7 are the
most common alleles. DRD4 was amplified by using the
two proceeding primer sequences: forward, 5'-AGGAC-
CCTCATGGCCTTG-3' (fluorescently labeled), and
reverse, 5'-GCGACTACGTGGTCTACTCG-3'. This assay
resulted in PCR products of 379, 427, 475, 523, 571, 619,
667, 715, 763, and 811 base pairs[19]. The two most com-
mon alleles in the Add Health sample were the 4-repeat
and the 7-repeat. Following prior research[19], we pooled
together the 379 (2R), 427 (3R), 475 (4R), 523 (5R), and
571 (6R) bp alleles and pooled together the 619 (7R), 667
(8R), 715 (9R), and 763 (10R) bp alleles. Subjects were
then classified into three groups based on the number of
7R alleles that each subject possessed. Sixty-four percent
of the sample possessed zero 7R alleles, 31 percent of the
sample possessed one 7R allele, and 5 percent of the sam-
ple possessed two 7R alleles. Racial differences in the dis-
tribution of 7R alleles was examined and the results
revealed that African Americans possessed significantly
more 7R alleles than non-Hispanic Caucasians (χ2 = 5.94,
df = 2, p = .051).
Statistical analysis
Since the dependent variables used in our analyses are
count measures and therefore represent a Poisson distri-
bution, we employed negative binomial regression analy-
ses to examine the independent and interactive effects of
DRD2 and DRD4 on conduct disorder and antisocial
behavior. All models were calculated using Huber/White
variance estimates to account for the non-independence
in some of the observations. We estimated five different
statistical models: one for each of the three conduct disor-
der scales, one for the lifetime conduct problems scale,
and one for the composite index of antisocial behavior. To
examine the possibility that the two genes may interact
with each other, we created an interaction term by multi-
plying DRD2 and DRD4. In order to reduce problems of
collinearity, the main effect terms were mean centered
Table 1: Descriptive statistics for the antisocial phenotype measures
Measure Mean Standard Deviation Range
Conduct disorder at wave 1 1.28 1.95 0–12
Conduct disorder at wave 2 .33 .82 0–7
Conduct disorder at wave 3 .40 .77 0–7
Lifetime conduct problems .67 .91 0–5.67
Composite antisocial behavior index .08 .29 0–2Behavioral and Brain Functions 2007, 3:30 http://www.behavioralandbrainfunctions.com/content/3/1/30
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prior to constructing the gene × gene interaction term[35].
We also calculated variance inflation factors and tolerance
limits to ensure that our analyses were not affected by
multicollinearity. Based on these diagnostic estimates, no
violations were detected. Hardy-Weinberg equilibrium
was fulfilled for both DRD2 (χ2 = 1.86, df = 1, p = .173)
and DRD4 (χ2 = 2.20, df = 1, p = .138) in the Add Health
sample and we had adequate statistical power (80%) to
detect an effect size of .35.
Results
Table 2 contains the results of the negative binomial
regression equations employing the three conduct disor-
der scales as dependent variables. The left hand side of the
table reveals that DRD2 has a marginally significant effect
on conduct disorder (b = .141, p = .059), whereas DRD4
does not exert an independent effect on the wave 1 con-
duct disorder scale (b = .036, p = .656). However, the inter-
action between DRD2 and DRD4 is a statistically
significant predictor of conduct problems (b = .269, p =
.030), even after partitioning out the effects of age and
race.
Individuals possessing the A-1 allele and the 7R allele are
significantly more likely to develop conduct problems in
adolescence.
Similar results were garnered for the equations predicting
the wave 2 conduct disorder scale. DRD2 (b = .102, p =
.408) and DRD4 (b = .014, p = .909) fail to maintain a sta-
tistically significant association with conduct problems.
In contrast, the interaction between these two genes has a
statistically significant effect (b = .486, p = .011) on con-
duct disorder. The pattern of finding for the wave 3 con-
duct disorder scale mirrors those for the wave 2 conduct
disorder scale; DRD2 (b = .030, p = .769) and DRD4 (b =
-.023, p = .812) fail to have a significant effect on conduct
disorder, but the interaction between DRD2 and DRD4
has a significant effect (b = .322, p = .039) on the wave 3
conduct disorder scale.
Table 3 presents the results of the negative binomial
regression equations predicting the lifetime conduct prob-
lems scale and the composite index of antisocial behavior.
The coefficients displayed under the first column show
that DRD2 (b = .096, p = .127) and DRD4 (b = .041, p =
.575) do not have significant independent effects on life-
time conduct problems scale. However, the interaction
between DRD2 and DRD4 has a significant effect (b =
.296, p = .003) on the lifetime conduct problems scale.
The second column in Table 3 uses the composite index of
antisocial behavior as the dependent variable. DRD2 (b =
.205, p = .189) and DRD4 (b = -.113, p = .600) do not
maintain significant associations with the measure of
antisocial behavior. However, the interaction between
DRD2 and DRD4 again emerges as a significant predictor
(b = .656, p = .004).
Discussion and conclusion
We examined whether two dopaminergic polymorphisms
– DRD2 and DRD4 – were related to conduct disorder and
adult antisocial behavior. The results of the statistical
models revealed that DRD2 and DRD4 did not have con-
sistent main effects on antisocial phenotypes. However,
for all five of the equations estimated, DRD2 interacted
with DRD4 to predict variation in the conduct disorder
scales and variation in the composite index of antisocial
behavior. These findings thus provide initial evidence of a
gene × gene interaction on conduct disorder and antiso-
cial behavior in a sample of males. The results are consist-
ent with other biological studies which point to the likely
interaction of several genes in producing complex disor-
ders such as autism[36] and schizophrenia[37].
The statistical analyses employed in this study were only
able to demonstrate that a correlation existed between the
antisocial phenotypes and the gene × gene interaction.
Correlations, of course, do not imply causation and stand-
ard statistical techniques, such as the ones used here, are
unable to provide much information about the causal
processes that might lead from the gene × gene interaction
Table 2: The independent and interactive effects of DRD2 and DRD4 on conduct disorder
Conduct Disorder at Wave 1 Conduct Disorder at Wave 2 Conduct Disorder at Wave 3
b SE zpb SE zpb SE zp
Polymorphisms
DRD2 .141 .07 1.89 .059 .102 .12 .83 .408 .030 .10 .29 .769
DRD4 .036 .08 .45 .656 .014 .12 .11 .909 -.023 .10 -.24 .812
DRD2 × DRD4 .269 .12 2.17 .030 .486 .19 2.55 .011 .322 .15 2.07 .039
Control variables
Age -.055 .03 -1.80 .072 -.038 .05 -.83 .407 -.121 .04 -3.38 .001
Race .246 .12 2.08 .038 .643 .18 3.56 .001 .317 .15 2.07 .039Behavioral and Brain Functions 2007, 3:30 http://www.behavioralandbrainfunctions.com/content/3/1/30
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to conduct disorder or to adult antisocial behavior. Recent
theoretical work by Sagvolden and his colleagues[38],
however, is useful in shedding some light on how
dopaminergic polymorphisms, such as DRD2 and DRD4,
may lead to various forms of psychopathology. According
to the dynamic developmental behavioral theory pro-
posed by Sagvolden et al, a hypofunctioning mesolimbic
dopamine system is largely responsible for producing
alterations in behavioral reinforcement and extinction,
which, in turn, disrupts learning processes. These dis-
rupted learning processes coupled to a hypofunctioning
mesocortical dopamine pathway can cause the emergence
of ADHD and ADHD-like symptoms.
Although Sagvolden et al's theory was designed to provide
a causal explanation to the etiology of ADHD, it is possi-
ble that this theoretical perspective may extend to non-
ADHD phenotypes, such as antisocial behavior.
Sagvolden et al, for example, often make reference to the
fact that altered dopaminergic functioning has effects on
behavioral disinhibition. There is now an impressive
amount of research revealing that many types of antisocial
behaviors, including violence and aggression, are linked
to an inability to control impulses and to a lack of behav-
ioral inhibition [39]. Perhaps Sagvolden et al's model is
much broader in scope, where ADHD is just one symp-
tom of a larger constellation of phenotypes – including
conduct disorder and adult antisocial behavior – that can
be explained by the dynamic developmental behavioral
theory.
With this in mind, it is important to touch upon the main
limitations of our study. First, the Add Health data did not
contain information about a clinical diagnosis of conduct
disorder, thus we used measures that approximated con-
duct disorder. The measures used to construct the conduct
disorder scales were based largely on overt forms of phys-
ical violence. Of course, conduct disorder also includes
more covert types of behavior, such as stealing and van-
dalism. Although prior researchers examining genetic
influences with the Add Health data have used a similar
strategy and similar items to tap conduct disorder[6], it is
possible that the gene × gene interaction is only associated
with overt physical aggression. Extant research has
revealed that heritability estimates fluctuate depending on
whether aggression is measured through covert behaviors
or overt behaviors[40]. As a result, replication studies
should address this possibility and examine whether the
gene × gene interaction is found for covert antisocial phe-
notypes.
On a related note, conduct disorder is often comorbid
with drug use and sensation seeking. At the same time,
DRD2 and DRD4 have been found to be related these dif-
ferent phenotypes[11,41-43], thus raising the possibility
that the gene × gene interaction is spurious, with the con-
founding factors being drug dependence. Research is
needed to examine whether the interaction between
DRD2 and DRD4 is observed in other samples and, if so,
if other phenotypes (e.g., drug use) can explain this asso-
ciation.
It is also important to point out that only a subsample of
respondents from the Add Health data submitted sample
of their DNA for genotyping. This raises the possibility
that the sample used in the analyses is not a nationally-
representative cross-section of American males. Similarly,
thus far the Add Health respondents have only been
tracked through young adulthood. Whether the gene ×
gene interaction would be detected later in life is an
empirical question that subsequent research needs to
investigate.
We close by noting that although our findings point to the
possibility that antisocial phenotypes may be partially the
result of an interaction between DRD2 and DRD4, it is
possible that other genes that are in close linkage with
DRD2 and DRD4 may actually be driving this effect. Anal-
yses that examine haplotype blocks would begin to eluci-
date the true causal genetic variants to behavioral
Table 3: The independent and interactive effects of DRD2 and DRD4 on lifetime conduct problems and composite index of antisocial 
behavior
Lifetime Conduct Problems Composite Index of Antisocial Behavior
b SE zp b SE zp
Polymorphisms
DRD2 .010 .06 1.52 .127 .205 .16 1.31 .189
DRD4 .041 .07 .56 .575 -.113 .22 -.52 .600
DRD2 × DRD4 .296 .10 3.00 .003 .656 .23 2.85 .004
Control variables
Age -.084 .03 -3.18 .001 -.080 .06 -1.25 .210
Race .338 .11 3.14 .002 .557 .26 2.11 .035Behavioral and Brain Functions 2007, 3:30 http://www.behavioralandbrainfunctions.com/content/3/1/30
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phenotypes. Future research will have to explore these
possibilities. As for now, our research draws attention to
the importance of analyzing whether multiple polymor-
phisms work in concert to bring about phenotypic differ-
ences.
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